Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Context Therapeutics Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +1 vs. Q2 2023
- Shares held
- 2.58M
- +339.5K (+15.2%) vs. Q2 2023
- Total value
- $3.89M
- +$311.3K (+8.7%) vs. Q2 2023
- New holders
- 3
- 7 more added
- Sold out
- 2
- 1 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $34.8M |
| Q1 2026 | 60 | $194.6M |
| Q4 2025 | 43 | $96.0M |
| Q3 2025 | 37 | $66.8M |
| Q2 2025 | 39 | $45.0M |
| Q1 2025 | 42 | $43.7M |
| Q4 2024 | 52 | $76.4M |
| Q3 2024 | 42 | $111.2M |
| Q2 2024 | 34 | $114.3M |
| Q1 2024 | 25 | $5.43M |
| Q4 2023 | 24 | $4.02M |
| Q3 2023 | 23 | $3.89M |
| Q2 2023 | 22 | $3.58M |
| Q1 2023 | 22 | $722.6K |
| Q4 2022 | 24 | $2.55M |
| Q3 2022 | 24 | $4.59M |
| Q2 2022 | 20 | $6.32M |
| Q1 2022 | 16 | $6.30M |
| Q4 2021 | 19 | $9.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ally Bridge Group (NY) LLC | 725,951 | $1.10M | 1.29% | +72,555+11.1% | Added |
| Vanguard Group Inc | 593,491 | $896.2K | 0.00% | +18,791+3.3% | Added |
| Affinity Asset Advisors, LLC | 328,817 | $496.5K | 0.16% | +61,243+22.9% | Added |
| UBS Oconnor LLC | 295,700 | $446.5K | 0.01% | +230,072+350.6% | Added |
| HighTower Advisors, LLC | 125,852 | $190.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 105,809 | $159.8K | 0.00% | 00.0% | Unchanged |
| Mill Creek Capital Advisors, LLC | 104,631 | $158.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 97,240 | $146.9K | 0.00% | −9,994−9.3% | Reduced |
| Northern Trust Corp | 37,219 | $56.2K | 0.00% | 00.0% | Unchanged |
| Clear Harbor Asset Management, LLC | 36,000 | $54.4K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 32,907 | $49.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 30,100 | $45.0K | 0.00% | +1,800+6.4% | Added |
| Sheets Smith Wealth Management | 20,000 | $30.2K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 13,259 | $20.0K | 0.00% | +13,259 | New |
| Citadel Advisors LLC | 10,438 | $15.8K | 0.00% | +10,438 | New |
| Aspire Wealth Management Corp | 10,000 | $15.1K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,963 | $13.5K | 0.00% | +3,026+51.0% | Added |
| Advisor Group Holdings, Inc. | 1,500 | $2.27K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 400 | $604 | 0.00% | 00.0% | Unchanged |
| Retirement Group, LLC | 155 | $234 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 108 | $163 | 0.00% | +1+0.9% | Added |
| Bank of America Corp | 100 | $151 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 16 | $24 | 0.00% | +16 | New |
| Difesa Capital Management, LP | 0 | $0 | 0.00% | −34,878−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −26,839−100.0% | Sold out |